Abstract
Materials and methods
ficance was regarded as P-values <0.05.
Subjects

Results
Twenty eight adult patients (14 men; age 54.5±17.7 years, range 21.5-81 years) receiving continuous ambulatory peritoneal dialysis (CAPD) treatment for ESRD gave written Plasma leptin concentrations ranged from 1.3 to informed consent to a protocol approved by the Human 505 mg/l in the 28 study subjects. Because of the wellStudies Committee of Washington University. Renal failure known sexual dimorphism in leptin levels [25] [26] [27] [28] , all was due to diabetes mellitus in 12 (10 were receiving insulin), of the results concerning leptin concentrations are glomerulonephritis in seven, hypertension in five and HIV separated by sex for presentation. Because leptin levels infection, lupus, reflux nephropathy and polycystic kidney increase in normals and renal failure patients with disease in one subject each. Medications received by the increasing adiposity [11, 12] , results from CAPD subsubjects included erythropoietin by 23, antihypertensives by jects were compared with sex-and BMI-matched con-19, warfarin by three, thyroxine by four and anti-depressants trols ( Table 1) . Plasma leptin concentrations in male by four; one patient was receiving prednisone and two were receiving replacement estrogens. Insulin therapy for the CAPD subjects were three-fold higher but not statisticdiabetics was administered by standard sub-cutaneous regi-ally different from those of BMI-matched controls mens (mean dosage 55±31 U/day, range 8-95 U/day). All (P=0.078). In females, leptin concentrations were patients were performing four exchanges daily, except for seven-fold higher than in BMI-matched controls two who were performing five exchanges; exchange volumes (P<0.001), and 12 of the 14 women had concentrations were 2.0 or 2.5 l per exchange. Patients had been treated exceeding 130 mg/l. The highest leptin concentration in with peritoneal dialysis for 18±20 months (range 0.5-94 a control was 82.2 mg/l (BMI 42.5 kg/m2). Thus frank months). Dialysis adequacy was assessed by measuring Kt/V hyperleptinaemia of renal failure was more pronounced of urea, which was determined by collecting 24-h drained in women. Repeated measurements of leptin over dialysate and urine specimens followed by blood samples.
months showed that concentrations in CAPD subjects
Kt/V urea, calculated by standard methods [23], averaged 2.09±0.53 (range 1.31-3.99) in these patients. The same were stable, with modest variation consistent with specimens were used for determination of leptin clearance. previously reported biological variation seen in norNormal adults (n=28; age 36.8±8.0 years, range 24-52 mals [24] . The relationship of plasma leptin with BMI years) paired to match the CAPD subjects for sex and body was disrupted in female and decreased in male CAPD mass index (BMI ) served as controls. subjects; whereas the control groups had strong corSpecimens for leptin analysis were drawn during daylight relations (r=0.772, P=0.001 for men; r=0.774, P= hours when subjects appeared for routine office assessment 0.001 for women), poorer correlations were determined of dialysis therapy; the subjects were receiving their normal for CAPD men and women (r=0.522, P=0.055 and diet. Specimens for combined leptin and insulin determinar=0.155, P=0.596, respectively). tion were drawn after the subjects drained their dialysis fluid Leptin concentrations in dialysis fluid ranged from without overnight replacement and an overnight fast. None of the subjects were studied during intercurrent illness (except <0.5 to 62.5 mg/l in individual collections, and concenfor the one HIV-infected subject), including peritonitis, and trations for the set of four (or five) dialysates that were none were enrolled in active weight-management programs. generated in a 24-h period by one individual were similar (data not shown). Leptin excretion ranged Analytical methods from 5.3 to 148.5 mg/day (average 34.1±39.4 mg/day) for men and 27.3 to 323 mg/day (average 200.7± Plasma leptin concentrations were measured with a commer-100.0 mg/day) for women CAPD subjects. There cial radioimmunoassay (Linco Research, St. Charles, MO, was a strong correlation of daily excretion with USA), which was based on polyclonal antibody to recombin-plasma leptin concentration for both women (r=0.747, ant human leptin, recombinant human leptin for standards P=0.002) and men (r=0.929, P<0.001). The regresand tracer, and a second antibody method for separation of sion equations relating 24-h leptin excretion to plasma bound and free leptin. This method, which will detect 0.5 mg/l concentrations were different for men (excretion= leptin in plasma, has been characterized extensively [24] .
1.55×plasma concentration+5.8 mg/l ) and women Long-term interassay coefficients of variation are 11.0% at 2.6 mg/l and 10.9% at 13.5 mg/l. Urea, creatinine, albumin (excretion=0.62×plasma concentration+66.8 mg/l ) and total protein analyses were performed by Spectra ( Figure 1 ).
Laboratories (Freemont, CA, USA). C-Reactive protein
The clearance of leptin by dialysis was compared analyses were performed on a Beckman Array 360 (Brea, with the clearance of creatinine, b 2 -microglobulin and CA, USA) using reagents provided by the manufacturer.
total protein ( Table 2 ). Leptin clearance in dialysate was much higher in men (1.7±0.9 ml/min) than Statistical methods women (0.7±0.3 ml/min) (P<0.001). Clearance of creatinine, b 2 -microglobulin and protein by dialysis, Results are expressed as means±SD unless specified other-averaged over 24 h, were similar in men and women wise. Grouped data were analyzed using Student's paired CAPD patients ( , r=0.253, P=0.584) . A related concern is the potential of the glucose content of the dialysis fluid to chronically increase insulin, and thereby increase circulating leptin concentrations. To test this hypothesis, we sought to correlate the total glucose content of dialysis fluid administered daily (range 125-425 g/day) with plasma leptin concentrations; in both men and women CAPD subjects there was no significant correlation (r=0.168, P=0.566 and r=0.404, P=0.151, respectively). Plasma albumin concentrations are frequently low in CAPD subjects, and are thought to reflect nutritional state. Since nutritional state can strongly influence leptin concentrations [29] [30] [31] , we correlated plasma leptin with albumin concentrations in the same specimens; there was no significant correlation in either men (r=0.298, P= trations [21,22], we measured C-reactive protein levels in the CAPD cohort; there was no significant correla- approached significance (P=0.057). Residual renal function, measured as urinary creatinine clearance, was examined in relation to plasma leptin concentrations; substances was similar in women (P=0.161) but the there was no significant correlation in male CAPD much higher clearance of leptin resulted in a highly subjects (r=0.134, P=0.648) but there was a positive significant difference in men (P=0.001). Also, clearcorrelation in women (r=0.634, P=0.015). This positances of leptin and b 2 -microglobulin were highly correlive correlation is unlikely to explain hyperleptinaemia ated in women (r=0.764, P=0.004), but unrelated in since decreasing renal function (not the increasing men (r=0.024, P=0.940). Several parameters related relationship suggested by the correlation) is associated to dialysis efficiency/renal function were compared with elevated leptin concentrations. Also, plasma leptin between men and women CAPD subjects. Kt/V, daily was not significantly related to plasma b 2 -microglobuglucose load in dialysate, creatinine clearance, age and lin concentrations in either men (r=0.347, P=0.27) length on dialysis were similar between the two groups (all P>0.17). Dialysate Kt/V was significantly higher or women (r=0.398, P=0.20). Repeating these cor-relations, using ln leptin in place of raw plasma leptin ination combined with increased production, the increased production likely overwhelms the adaptive concentrations, yielded very similar results (data not shown).
elimination capacity and results in the hyperleptinemic state. Hyperinsulinemia or inflammation are potential As a final examination of the data for determinants of hyperleptinaemia in CAPD subjects, stepwise for-important causes of increased production in ESRD, based on correlations of leptin concentrations with ward multiple regression was performed with plasma leptin as the dependent variable, and the following plasma insulin or C-reactive protein [8, 17] , but no evidence for these causes was found in the CAPD independent variables: BMI, urinary creatinine clearance, plasma albumin concentration, daily dialysis fluid cohort studied here. Previous studies have noted that hyperleptinemia is much more prevalent in obese glucose load, daily leptin in dialysis fluid, plasma C-reactive protein and Epo dose per week. In the ESRD subjects (defined as BMI >28 kg/m2) after taking into account the increased levels seen in obesity model derived for male CAPD subjects, Epo dose explained 25% and BMI 22% of the variation in leptin in normals [5, 6 ] . The women in the present study had an average BMI of 30.1 kg/m2, which was significantly between subjects, the other variables were not significantly contributory. For the female subjects, the model greater (P=0.042) than that of male subjects (25.7 kg/m2). Also, BMI was a significant determinant found that urinary creatinine clearance (39% of variation), C-reactive protein concentration (23%) and of plasma leptin concentrations in forward stepwise multiple regression for men CAPD subjects. The higher Epo dose (7%) were significant determinants of leptin concentration. The effect of Epo in both of the models plasma concentrations of leptin seen in obese subjects are due to increased production of leptin [35] , so the was negative, in keeping with an earlier report [32] . As in single regression analysis (see above), increasing obese state is a high-production state. Several studies have documented that women have higher leptin concreatinine clearance was associated with increasing plasma leptin concentrations and is not likely to be centrations than men, even after adjusting for the differences in adiposity between men and women meaningful. The association of C-reactive protein in the model derived for women PD subjects was negative, [25] [26] [27] [28] ; this sexual dimorphism likely results from effects of sex hormones on leptin production, since and therefore the opposite of the relationship predicted by preceding work. Thus, Epo dose was the only testosterone and estrogen have been shown to regulate leptin production [35] [36] [37] [38] . Also, women CAPD subconsistent determinate of leptin concentrations among these variables. Repeating the multiple regression ana-jects have higher percent body fat than men at the same BMI. Although use of direct measures of body lyses, replacing plasma leptin with ln leptin as the dependent variable, generated very similar findings composition such as dual excitation X-ray absorptiometry would likely reduce the sexual dimorphism except that epo dose was no longer a significant determinant of leptin concentration for either men or found in the BMI-based data presented here [8, 39] , women CAPD subjects still produce more leptin as a women (data not shown).
consequence of higher percent body fat. These data and recent studies suggest that obesity, inflammation,
Discussion
hyperinsulinism and potentially female gender are causes of higher production of leptin in the hyperleptinaemia of ESRD. The hyperleptinaemia of ESRD has resisted convincing analysis of causation; the idea that leptin simply accu-
The clearance of leptin in dialysate of CAPD subjects is readily measurable but accounts for only a tiny mulates as renal elimination decreases is untenable since many individuals without renal function (includ-fraction of the leptin produced daily, based on measurements of leptin production in normals. If the halfing surgically anephric subjects) have leptin concentrations appropriate for their degree of adiposity, and life of leptin in plasma in CAPD subjects is similar to that of normals (about 25 min) [35] , and the volume leptin concentrations do not correlate strongly with measures of residual renal function such as urinary of distribution is the intravascular plasma volume (about 3 l ), then a patient with a plasma leptin concencreatinine clearance [5] [6] [7] [8] [9] [10] . Leptin production may decrease in ESRD to compensate for reduced elimina-tration of 140 mg/l would produce about 10 mg/day of leptin [40] . Postulating a larger volume of distribution tion capacity, but there is no evidence currently available to suggest reduced production in hyperleptinaemic requires even higher daily leptin production. Daily leptin cleared in dialysis fluid in our CAPD subjects states, and the high leptin levels observed in obesity argue against such negative regulation of production never exceeded 350 mg per day, even in subjects with very high (>500 mg/l ) plasma leptin concentrations. [11, 12] . Two recent studies of nephrectomized rats demonstrated rapid adaptation to the loss of leptin In male subjects plasma leptin concentrations were much lower (18.2±23.6 mg/l ) but so was average daily elimination, which restored prenephrectomy leptin concentrations within 24 h [33, 34] . The studies suggested leptin in dialysate (34.1±34.4 mg/l/day). Thus leptin elimination in dialysate is not the major elimination that loss of renal function in ESRD subjects may result in compensating leptin elimination by other tissues.
route in CAPD subjects, and CAPD subjects likely possess alternative means of eliminating leptin from The results presented here advance the hypothesis that the hyperleptinaemia observed in many CAPD circulation.
The dialytic clearance rates for leptin between men subjects results from a predisposing loss of renal elim-obese gene product on body weight regulation in ob/ob mice. and women CAPD subjects were very different. Also, Science 1995; 269: 540-543 the dialysis clearance rates of b 2 -microglobulin and
